Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice
Open Access
- 30 December 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (1) , 92
Abstract
Type 2 diabetes mellitus (T2DM) has become epidemic worldwide and is strongly associated with nonalcoholic fatty liver disease (NAFLD). The molecular mechanisms of microRNAs in NAFLD and T2DM development and the corresponding therapies remain unclear. We performed microRNA microarray validation to determine whether hepatic miR-34a-5p was significantly upregulated in db/db mice fed with a high-fat diet (HFD), a mouse model of T2DM with steatohepatitis. The potential role of miR-34a-5p and gallic acid (GA) in regulating hepatic lipid metabolism and diabetic steatosis was explored. GA improved the activities of antioxidant enzymes and suppressed lipid accumulation in the HFD-induced steatotic liver of db/db mice. In vitro, the silencing of miR-34a-5p in hepatocyte HepG2 cells ameliorated high glucose + oleic acid/palmitic acid mixture–induced accumulation of cellular triglycerides. We identified nuclear factor erythroid-derived 2-like 2 (NFE2L2) as a direct target of miR-34a-5p. Reduction in intracellular triglyceride and the expression levels of sterol regulatory element-binding protein 1 and fatty acid synthase by GA were mediated by the inhibition of miR-34a-5p expression in HepG2 cells. The findings suggest that GA improves hepatic lipogenesis by downregulating miR-34a-5p by suppressing NFE2L2 expression, indicating the potential therapeutic role of GA or an NFE2L2-activating agent in diabetic fatty liver disease.Keywords
Funding Information
- Ministry of Science and Technology Grant, Taiwan (MOST 109-2320-B-040 -024-)
This publication has 58 references indexed in Scilit:
- MicroRNA-34a regulates cardiac ageing and functionNature, 2013
- Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharidesJournal of Biomedical Science, 2012
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingProceedings of the National Academy of Sciences, 2011
- Effects of interventions on oxidative stress and inflammation of cardiovascular diseasesWorld Journal of Cardiology, 2011
- Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient dietToxicology and Applied Pharmacology, 2010
- Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-ImidazolideEuropean Journal of Pharmacology, 2009
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceCarcinogenesis, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding HeteroduplexesCell, 2006
- Glutathione peroxidase activity in selenium-deficient rat liverBiochemical and Biophysical Research Communications, 1976